Structure Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Structure Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2022 to Q3 2024.
  • Structure Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 172M shares, a 49.3% increase year-over-year.
  • Structure Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 110M shares, a 1050% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 172M +56.7M +49.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 148M +33.5M +29.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 140M +68.1M +95% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 110M +101M +1050% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 115M +105M +1075% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 115M +105M +1116% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 71.7M +62.6M +691% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 9.58M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 9.78M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 9.44M Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-11-17
Q1 2022 9.06M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.